Literature DB >> 22489805

Natural polypill Xuezhikang: its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions.

Yan Feng1, Hao Xu, Keji Chen.   

Abstract

Polypill has been a hot issue since it was first advanced in 2003. This new concept immediately spurred a worldwide discussion. Xuezhikang is a partially purified extract of fermented red yeast rice (Monascus purpureus). It is composed of 13 kinds of natural statins, unsaturated fatty acids, ergosterol, amino acids, flavonoids, alkaloid, trace element, and other substances, and thus could be regarded as a natural lipid-lowering polypill. Interestingly, Xuezhikang in the China Coronary Secondary Prevention Study trial lowered lipid levels less as compared with provastatin in the Cholesterol and Recurrent Events trial, but seemed to gain more benefit in reducing the cardiovascular events and the risk of death from cancer. In recent years, Xuezhikang has been further demonstrated to have additional health benefits and thus raised great interest. This article reviews the clinical benefits of Xuezhikang and the potential multicomponent synergetic mechanism. The authors hold that polypill is anticipated to be a more effective and feasible way to treat complicated diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489805     DOI: 10.1089/acm.2011.0187

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  7 in total

Review 1.  Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

Authors:  Ehete Bahiru; Angharad N de Cates; Matthew Rb Farr; Morag C Jarvis; Mohan Palla; Karen Rees; Shah Ebrahim; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

2.  Traditional Chinese medicine for acute coronary syndrome: A meta-analysis of clinical manifestations and objective indicators.

Authors:  Jiangquan Liao; Tao Li; Yingying Hua; Mingjing Shao; Yan Wang; Zhe Wang; Kangkang Wei; Jiangmeng Chang; Xiaoqiong Zhang; Ming Chen; Xianlun Li; Jinhang Du
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

Review 3.  Integrative Western and chinese medicine on coronary heart disease: where is the orientation?

Authors:  Siming Li; Hao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

Review 4.  Chinese herbal medicine on dyslipidemia: progress and perspective.

Authors:  Ming Guo; Yue Liu; Zhu-Ye Gao; Da-Zhuo Shi
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-13       Impact factor: 2.629

5.  Red Yeast Rice Protects Circulating Bone Marrow-Derived Proangiogenic Cells against High-Glucose-Induced Senescence and Oxidative Stress: The Role of Heme Oxygenase-1.

Authors:  Jung-Tung Liu; Huey-Yi Chen; Wen-Chi Chen; Kee-Ming Man; Yung-Hsiang Chen
Journal:  Oxid Med Cell Longev       Date:  2017-05-06       Impact factor: 6.543

6.  Walker 256 Tumor Growth Suppression by Crotoxin Involves Formyl Peptide Receptors and Lipoxin A₄.

Authors:  Patrícia Brigatte; Odair Jorge Faiad; Roberta Cornélio Ferreira Nocelli; Richardt G Landgraf; Mario Sergio Palma; Yara Cury; Rui Curi; Sandra Coccuzzo Sampaio
Journal:  Mediators Inflamm       Date:  2016-04-12       Impact factor: 4.711

7.  Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy.

Authors:  Rongrong Sun; Jiangbo Wang; Yi Zheng; Xianchi Li; Tiantian Xie; Rui Li; Min Liu; Yong Cao; Lei Lu; Qing Zhang; Peiying Zhang
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.